Marketdash
Back to News

Four Fresh Buy Ratings Hit the Street, Led by Bullish Oklo Coverage

MarketDash Editorial Team
3 days ago
Wall Street analysts kicked off Friday with four new buy ratings spanning nuclear energy, therapeutics, and organic eggs. Needham sees upside in Oklo and Centrus Energy, while BTIG and Needham target Palvella Therapeutics and Vital Farms with ambitious price targets.

Friday brought a fresh batch of optimism from Wall Street analysts, with four companies earning inaugural Buy ratings and ambitious price targets.

Leading the pack was Oklo Inc. (OKLO), the nuclear energy company that caught Needham analyst Sean Milligan's attention. Milligan launched coverage with a Buy rating and set a $135 price target on the stock. That represents meaningful upside from Thursday's closing price of $111.65, suggesting Milligan sees roughly 21% potential appreciation ahead.

Milligan also turned his attention to another player in the nuclear space, initiating coverage on Centrus Energy Corp (LEU) with a Buy rating and a $357 price target. Centrus closed Thursday at $278.63, giving it the highest absolute price among Friday's initiations. The analyst clearly sees momentum in nuclear energy companies as power demand concerns and clean energy transitions keep the sector in focus.

Switching sectors entirely, BTIG analyst Jeet Mukherjee initiated coverage on Palvella Therapeutics Inc (PVLA) with a Buy rating and a $167 price target. The biotech company closed Thursday at $93.80, meaning Mukherjee is projecting nearly 78% upside if his thesis plays out. That's the kind of target that gets investors' attention, especially in the therapeutics space where clinical progress can dramatically reshape valuations.

Rounding out Friday's initiations was Vital Farms, Inc. (VITL), the organic egg and dairy producer that earned a Buy rating from Needham analyst Gerald Pascarelli. His $45 price target compares to Thursday's close of $31.46, implying roughly 43% upside potential. It's not every day you see nuclear energy companies and organic egg producers sharing the same analyst coverage roundup, but here we are.

The common thread? Analysts see meaningful room for these stocks to run from current levels, whether you're betting on the nuclear renaissance, biotech breakthroughs, or the continued premiumization of breakfast staples.

Back to News

Four Fresh Buy Ratings Hit the Street, Led by Bullish Oklo Coverage

MarketDash Editorial Team
3 days ago
Wall Street analysts kicked off Friday with four new buy ratings spanning nuclear energy, therapeutics, and organic eggs. Needham sees upside in Oklo and Centrus Energy, while BTIG and Needham target Palvella Therapeutics and Vital Farms with ambitious price targets.

Friday brought a fresh batch of optimism from Wall Street analysts, with four companies earning inaugural Buy ratings and ambitious price targets.

Leading the pack was Oklo Inc. (OKLO), the nuclear energy company that caught Needham analyst Sean Milligan's attention. Milligan launched coverage with a Buy rating and set a $135 price target on the stock. That represents meaningful upside from Thursday's closing price of $111.65, suggesting Milligan sees roughly 21% potential appreciation ahead.

Milligan also turned his attention to another player in the nuclear space, initiating coverage on Centrus Energy Corp (LEU) with a Buy rating and a $357 price target. Centrus closed Thursday at $278.63, giving it the highest absolute price among Friday's initiations. The analyst clearly sees momentum in nuclear energy companies as power demand concerns and clean energy transitions keep the sector in focus.

Switching sectors entirely, BTIG analyst Jeet Mukherjee initiated coverage on Palvella Therapeutics Inc (PVLA) with a Buy rating and a $167 price target. The biotech company closed Thursday at $93.80, meaning Mukherjee is projecting nearly 78% upside if his thesis plays out. That's the kind of target that gets investors' attention, especially in the therapeutics space where clinical progress can dramatically reshape valuations.

Rounding out Friday's initiations was Vital Farms, Inc. (VITL), the organic egg and dairy producer that earned a Buy rating from Needham analyst Gerald Pascarelli. His $45 price target compares to Thursday's close of $31.46, implying roughly 43% upside potential. It's not every day you see nuclear energy companies and organic egg producers sharing the same analyst coverage roundup, but here we are.

The common thread? Analysts see meaningful room for these stocks to run from current levels, whether you're betting on the nuclear renaissance, biotech breakthroughs, or the continued premiumization of breakfast staples.